Preserving Neurocognition Without Compromising Tumor Control During Whole-Brain Radiotherapy Therapy In Patients With Numerous Brain Metastases Via A Novel Superoxide Dismutase Mimetic: Initial Safety Lead-In And Design Of A Clinical Trial
Publication
, Conference
Kirkpatrick, JP; Crapo, J; Floyd, SR; Torok, JAJ; Franklin, H; Anders, CK; Kelsey, CR; Blitzblau, RC; Fecci, P; Clarke, J; Peters, KB
Published in: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2020
Duke Scholars
Published In
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
EISSN
1879-355X
ISSN
0360-3016
Publication Date
2020
Volume
108
Issue
3
Start / End Page
E719 / E719
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kirkpatrick, J. P., Crapo, J., Floyd, S. R., Torok, J. A. J., Franklin, H., Anders, C. K., … Peters, K. B. (2020). Preserving Neurocognition Without Compromising Tumor Control During Whole-Brain Radiotherapy Therapy In Patients With Numerous Brain Metastases Via A Novel Superoxide Dismutase Mimetic: Initial Safety Lead-In And Design Of A Clinical Trial. In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (Vol. 108, pp. E719–E719).
Kirkpatrick, J. P., J. Crapo, S. R. Floyd, JA Jr Torok, H. Franklin, C. K. Anders, C. R. Kelsey, et al. “Preserving Neurocognition Without Compromising Tumor Control During Whole-Brain Radiotherapy Therapy In Patients With Numerous Brain Metastases Via A Novel Superoxide Dismutase Mimetic: Initial Safety Lead-In And Design Of A Clinical Trial.” In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108:E719–E719, 2020.
Kirkpatrick JP, Crapo J, Floyd SR, Torok JAJ, Franklin H, Anders CK, et al. Preserving Neurocognition Without Compromising Tumor Control During Whole-Brain Radiotherapy Therapy In Patients With Numerous Brain Metastases Via A Novel Superoxide Dismutase Mimetic: Initial Safety Lead-In And Design Of A Clinical Trial. In: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2020. p. E719–E719.
Kirkpatrick, J. P., et al. “Preserving Neurocognition Without Compromising Tumor Control During Whole-Brain Radiotherapy Therapy In Patients With Numerous Brain Metastases Via A Novel Superoxide Dismutase Mimetic: Initial Safety Lead-In And Design Of A Clinical Trial.” INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 108, no. 3, 2020, pp. E719–E719.
Kirkpatrick JP, Crapo J, Floyd SR, Torok JAJ, Franklin H, Anders CK, Kelsey CR, Blitzblau RC, Fecci P, Clarke J, Peters KB. Preserving Neurocognition Without Compromising Tumor Control During Whole-Brain Radiotherapy Therapy In Patients With Numerous Brain Metastases Via A Novel Superoxide Dismutase Mimetic: Initial Safety Lead-In And Design Of A Clinical Trial. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2020. p. E719–E719.
Published In
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
EISSN
1879-355X
ISSN
0360-3016
Publication Date
2020
Volume
108
Issue
3
Start / End Page
E719 / E719
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences